Pancreatic Cancer Research

ResearcherGarvan Institute of Medical ResearchActive in the last 2 years

Michael Tayao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5224-0784; OpenAlex author ID A5059526917. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Pulsed priming with the FAK inhibitor narmafotinib enhances both gemcitabine/Abraxane and FOLFIRINOX chemotherapy response in pancreatic cancer Co-author DOI 10.64898/2026.07.23.740234↗
  2. Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis. Co-author DOI 10.1126/sciadv.adq4416↗
  3. Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response. Co-author DOI 10.1126/sciadv.adl1197↗
  4. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Co-author DOI 10.1038/s43018-023-00614-y↗
  5. Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status. Co-author DOI 10.1126/sciadv.abh0363↗
  6. Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0150338↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jaswinder Singh Samra · 2 shared papers, 2016–2021 · strength 0.14
  2. Anthony James Gill · 2 shared papers, 2016–2021 · strength 0.14
  3. Yingxiao Wang · 1 shared paper, 2021 · strength 0.08
  4. Ashleigh Parkin · 1 shared paper, 2021 · strength 0.08
  5. Claire Vennin · 1 shared paper, 2021 · strength 0.08
  6. Angela S. Y. Chou · 1 shared paper, 2021 · strength 0.08
  7. Shona Ritchie · 1 shared paper, 2021 · strength 0.08
  8. Thomas R. Cox · 1 shared paper, 2021 · strength 0.08
  9. Max Nobis · 1 shared paper, 2021 · strength 0.08
  10. Amber L. Johns · 1 shared paper, 2021 · strength 0.08
  11. Kendelle Joan Murphy · 1 shared paper, 2021 · strength 0.08
  12. Marina Pajic · 1 shared paper, 2021 · strength 0.08
  13. Cecilia R. Chambers · 1 shared paper, 2021 · strength 0.08
  14. Roger J. Daly · 1 shared paper, 2021 · strength 0.08
  15. Sean Michael Grimmond · 1 shared paper, 2021 · strength 0.08
  16. David Herrmann · 1 shared paper, 2021 · strength 0.08
  17. Brooke Pereira · 1 shared paper, 2021 · strength 0.08
  18. James R. W. Conway · 1 shared paper, 2021 · strength 0.08
  19. Australian Pancreatic Cancer Genome Initiative (APGI) · 1 shared paper, 2021 · strength 0.08
  20. Jennifer P. Morton · 1 shared paper, 2021 · strength 0.08
  21. Owen James Sansom · 1 shared paper, 2021 · strength 0.08
  22. Paul Timpson · 1 shared paper, 2021 · strength 0.08
  23. Andrew Victor Biankin · 1 shared paper, 2021 · strength 0.08
  24. Terence C. Chua · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.